Improvement of Crizotinib-resistant Leptomeningeal Carcinomatosis by Switching to Alectinib in a Case of Non-small Cell Lung Cancer Anaplastic Lymphoma Kinase (ALK) Translocation

Authors :: Masayuki Hanaoka
Nobumitsu Kobayashi
Masamichi Komatsu
Akane Kato
Shoji Yomo
Kazunari Tateishi
Source :: Haigan. 55:223-227
Publication Year :: 2015
Publisher :: Japan Lung Cancer Society, 2015.

Subjects :: Pulmonary and Respiratory Medicine
Alectinib
Crizotinib
business.industry
medicine.disease
Oncology
Cancer research
Anaplastic lymphoma kinase
Medicine
Non small cell
business
Lung cancer
ALK Translocation
medicine.drug

Tools